|
New year brings new delay for SkyePharma's Flutiform asthma inhaler
FierceDrugDelivery That's because the British drug delivery company now stands to face an additional delay of between 6 and 9 months in the approval process for its Flutiform asthma therapy. As Reuters and the UK's The Telegraph reported just before the holidays, … |
View full post on asthma – Google News